Novavax Inc said on Monday it was on track to begin a delayed US-based late-stage study of its experimental coronavirus vaccine later this month.
The company also said the vaccine, NVX-CoV2373, had gained the US Food and Drug Administration’s “fast-track” status and that expected data from the trial could support US authorization and approval.
Novavax, which is testing the drug in a late-stage study in the UK, last month postponed the start of the U.S. trial by roughly a month, due to delays in scaling up the manufacturing process.
A handful of companies are testing their experimental coronavirus shots in late-stage studies, and Pfizer Inc said on Monday its experimental Covid-19 vaccine was more than 90% effective, citing early data from a large-scale clinical trial.
A fast-track status allows companies to submit sections of a marketing application on a “rolling” basis as soon as some data becomes available, rather than wait for all the data before submitting the application.
Novavax is scheduled to report its quarterly results later on Monday.
The company’s shares were up nearly 8% at $97 before the bell, reversing from a fall earlier.
The company also said the vaccine, NVX-CoV2373, had gained the US Food and Drug Administration’s “fast-track” status and that expected data from the trial could support US authorization and approval.
Novavax, which is testing the drug in a late-stage study in the UK, last month postponed the start of the U.S. trial by roughly a month, due to delays in scaling up the manufacturing process.
A handful of companies are testing their experimental coronavirus shots in late-stage studies, and Pfizer Inc said on Monday its experimental Covid-19 vaccine was more than 90% effective, citing early data from a large-scale clinical trial.
A fast-track status allows companies to submit sections of a marketing application on a “rolling” basis as soon as some data becomes available, rather than wait for all the data before submitting the application.
Novavax is scheduled to report its quarterly results later on Monday.
The company’s shares were up nearly 8% at $97 before the bell, reversing from a fall earlier.
More News
Election uncertainty could hurt auto sales in May: Fada – Times of India
Latest Utkarsh Small Finance Bank FD rates: Senior citizens get up to 9.10%, general customers up to 8.5% – check revised list | India Business News – Times of India
Air India Express flight cancellation: Will passengers get full refund or flight rescheduling option? Here’s what the airline has said – Times of India